Clinical Trials · NCT07605052
A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 50
- Start date
- May 2026
- Locations
- 1 site, United States
- Primary endpoint
- AUCss: area under the total cagrilintide concentration-time curve at steady state after 5th dosing of cagrilintide